FDA Warns of Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology
The Food and Drug Administration (FDA) has notified healthcare professionals of the possibility of falsely elevated blood glucose results when using GDH-PQQ glucose test strips on patients who are receiving therapeutic products containing certain non-glucose sugars. These sugars can falsely elevate glucose results, which may mask significant hypoglycemia or prompt excessive insulin administration, leading to serious injury or death.
GDH-PQQ glucose monitoring measures a patientâ€™s blood glucose value using methodology that cannot distinguish between glucose and other sugars. Certain non-glucose sugars, including maltose, xylose, and galactose, are found in certain drug and biologic formulations, or can result from the metabolism of a drug or therapeutic product.
When these non-glucose sugars are present in the patientâ€™s blood, using a GDH-PQQ glucose test strip will produce an elevated glucose result which may suggest the need for clinical action. This can lead to inappropriate dosing and administration of insulin, potentially resulting in hypoglycemia, coma, or death.
In addition, cases of actual hypoglycemia may go unrecognized if the patient and healthcare practitioner rely solely on the test result obtained with the GDH-PQQ glucose test strips..
Other glucose test strip methodologies are not affected by the presence of non-glucose sugars. The unaffected methods are glucose oxidase, glucose dehydrogenase nicotine adenine dinucleotide (GDH-NAD), or glucose dehydrogenase flavin adenine dinucleotide (GDH-FAD).
To read the FDA alert, which lists all the safe glucose monitoring technologies, see the link below.
AUG-13-09: FDA Warns of Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology [FDA: WARNS OF ERROR WITH GDH-PQQ GLUCOSE MONITORING]
If you or a loved one has suffered adverse health effects from using this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Related Law Suits
FDA Warns of Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology Law Suit and Settlement
Forest Laboratories Potentially Illegal Marketing Law Suit and Settlement
FDA Law Suit and Settlement
CVS Law Suit and Settlement
Louisiana, USA Law Suit and Settlement
Miralus Inc. Law Suit and Settlement
Vytorin Law Suit and Settlement
Pesticides Law Suit and Settlement
Medtronic Inc. Law Suit and Settlement
Xiadafil VIP Law Suit and Settlement
See more stories from this source.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits
Related Law Articles
Related Law Questions
Related Law Bulletins
Lawyers! Become an Approved Expert to Answer Questions.
You'll get lots of targetted traffic to your website and new client leads!